Trial · NCT03048422
Results by group100
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 100
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Mothers With HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery | Arms 1 and 2: Maternal DTG+FTC/TAF and DTG+FTC/TDF | Intention-to-Treat Analysis | 97.5 | Percentage of participants | |
| Percentage of Mothers With HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery | Arm 3: Maternal EFV/FTC/TDF | Intention-to-Treat Analysis | 91.0 | Percentage of participants | |
| Percentage of Mothers With HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery | Arms 1 and 2: Maternal DTG+FTC/TAF and DTG+FTC/TDF | Per-Protocol Analysis | 97.5 | Percentage of participants | |
| Percentage of Mothers With HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery | Arm 3: Maternal EFV/FTC/TDF | Per-Protocol Analysis | 91.4 | Percentage of participants | |
| Percentage of Mother-infant Pairs With an Adverse Pregnancy Outcome | Arm 1: Maternal DTG+FTC/TAF | 24.1 | percentage of mother-infant pairs | ||
| Percentage of Mother-infant Pairs With an Adverse Pregnancy Outcome | Arm 2: Maternal DTG+FTC/TDF | 32.9 | percentage of mother-infant pairs | ||
| Percentage of Mother-infant Pairs With an Adverse Pregnancy Outcome | Arm 3: Maternal EFV/FTC/TDF | 32.7 | percentage of mother-infant pairs | ||
| Cumulative Probability of Women Experiencing Grade 3 or Higher Adverse Event | Arm 1: Maternal DTG+FTC/TAF | 25.1 | Cumulative probability per 100 persons | ||
| Cumulative Probability of Women Experiencing Grade 3 or Higher Adverse Event | Arm 2: Maternal DTG+FTC/TDF | 30.8 | Cumulative probability per 100 persons | ||
| Cumulative Probability of Women Experiencing Grade 3 or Higher Adverse Event | Arm 3: Maternal EFV/FTC/TDF | 27.9 | Cumulative probability per 100 persons | ||
| Cumulative Probability of Infants Experiencing Grade 3 or Higher Adverse Event | Arm 1 Infants | 25.3 | Cumulative probability per 100 persons | ||
| Cumulative Probability of Infants Experiencing Grade 3 or Higher Adverse Event | Arm 2 Infants | 28.6 | Cumulative probability per 100 persons | ||
| Cumulative Probability of Infants Experiencing Grade 3 or Higher Adverse Event | Arm 3 Infants | 30.9 | Cumulative probability per 100 persons | ||
| Percentage of Mothers With HIV-1 RNA Less Than 50 Copies/mL at Delivery Measured at Central Laboratory | Arms 1 and 2: Maternal DTG+FTC/TAF and DTG+FTC/TDF | 94.4 | percentage of participants | ||
| Percentage of Mothers With HIV-1 RNA Less Than 50 Copies/mL at Delivery Measured at Central Laboratory | Arm 3: Maternal EFV/FTC/TDF | 78.8 | percentage of participants | ||
| Percentage of Mothers With HIV-1 RNA Less Than 200 Copies/mL at 50 Weeks Postpartum | Arms 1 and 2: Maternal DTG+FTC/TAF and DTG+FTC/TDF | 96.3 | percentage of participants | ||
| Percentage of Mothers With HIV-1 RNA Less Than 200 Copies/mL at 50 Weeks Postpartum | Arm 3: Maternal EFV/FTC/TDF | 96.4 | percentage of participants | ||
| Time to First HIV-1 RNA Less Than 200 Copies/mL Through Delivery | Arms 1 and 2: Maternal DTG+FTC/TAF and DTG+FTC/TDF | 4.26 | Standard Error 0.09 | weeks | |
| Time to First HIV-1 RNA Less Than 200 Copies/mL Through Delivery | Arm 3: Maternal EFV/FTC/TDF | 6.49 | Standard Error 0.31 | weeks | |
| Percentage of Mothers With Virologic Success of HIV-1 RNA Less Than 200 Copies/mL at Delivery Based on FDA Snapshot Algorithm | Arm 1: Maternal DTG+FTC/TAF | 88.9 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03048422/results